Quantbot Technologies LP Makes New $768,000 Investment in Aspen Aerogels, Inc. (NYSE:ASPN)

Quantbot Technologies LP bought a new stake in Aspen Aerogels, Inc. (NYSE:ASPN) in the fourth quarter, Holdings Channel reports. The institutional investor bought 64,672 shares of the construction company’s stock, valued at approximately $768,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. FMR LLC lifted its position in Aspen Aerogels by 23.6% during the 3rd quarter. FMR LLC now owns 4,050,896 shares of the construction company’s stock worth $112,169,000 after buying an additional 773,647 shares in the last quarter. Prescott Group Capital Management L.L.C. acquired a new position in shares of Aspen Aerogels during the fourth quarter worth approximately $5,126,000. Telemark Asset Management LLC grew its stake in shares of Aspen Aerogels by 26.8% during the fourth quarter. Telemark Asset Management LLC now owns 1,892,424 shares of the construction company’s stock valued at $22,482,000 after purchasing an additional 400,000 shares during the last quarter. Lord Abbett & CO. LLC acquired a new stake in shares of Aspen Aerogels in the third quarter valued at approximately $10,126,000. Finally, Charles Schwab Investment Management Inc. raised its position in Aspen Aerogels by 204.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 509,430 shares of the construction company’s stock worth $14,106,000 after purchasing an additional 342,253 shares during the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have recently commented on ASPN. Canaccord Genuity Group lowered their target price on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a research note on Friday, February 14th. Craig Hallum cut their price target on Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating on the stock in a research note on Friday, February 14th. Seaport Res Ptn cut shares of Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 12th. B. Riley dropped their price target on Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating on the stock in a research report on Wednesday, February 19th. Finally, Roth Mkm reduced their target price on shares of Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating for the company in a research note on Friday, February 14th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $19.11.

Aspen Aerogels Stock Performance

ASPN opened at $7.04 on Thursday. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. Aspen Aerogels, Inc. has a 12-month low of $6.60 and a 12-month high of $33.15. The business has a 50 day moving average of $9.28 and a 200-day moving average of $14.94. The stock has a market cap of $577.77 million, a price-to-earnings ratio of 43.98 and a beta of 2.28.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. On average, equities research analysts expect that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.